Verkkoa review of the current landscape for rare diseases, which affect 300 million people worldwide and have high genetic and diagnostic complexity. Verkkowith the majority of the known rare diseases being of genetic origin, rna targeting by oligonucleotide therapies provides a key opportunity to reduce the. Verkkorare diseases remain a formidable public health challenge. The key to unlocking breakthroughs in diagnosis and treatment is fostering dynamic.
